2015
DOI: 10.1016/j.bmc.2015.07.061
|View full text |Cite
|
Sign up to set email alerts
|

Carbon nanotubes supported tyrosinase in the synthesis of lipophilic hydroxytyrosol and dihydrocaffeoyl catechols with antiviral activity against DNA and RNA viruses

Abstract: Hydroxytyrosol and dihydrocaffeoyl catechols with lipophilic properties have been synthesized in high yield using tyrosinase immobilized on multi-walled carbon nanotubes by the Layer-by-Layer technique. All synthesized catechols were evaluated against a large panel of DNA and RNA viruses, including Poliovirus type 1, Echovirus type 9, Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), Coxsackievirus type B3 (Cox B3), Adenovirus type 2 and type 5 and Cytomegalovirus (CMV). A significant a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
50
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 31 publications
(50 citation statements)
references
References 58 publications
0
50
0
Order By: Relevance
“…The oxidative functionalization of BTO 1 was then performed using tyrosinase supported on multi-walled carbon nanotubes (MWCNTs) applying the Layer by Layer (LbL) procedure previously developed. 26 Briey, oxidized MWCNTs 27 were treated with a positively charged poly(diallyldimethylammonium) chloride (PDDA) to facilitate the loading of tyrosinase, that is negatively charged at the operative pH 7. Bovine Serum Albumin (BSA) was used to reduce undesired conformational changes.…”
Section: Synthesis Of Dopa-derived Peptidomimetics In Heterogeneous Cmentioning
confidence: 99%
See 2 more Smart Citations
“…The oxidative functionalization of BTO 1 was then performed using tyrosinase supported on multi-walled carbon nanotubes (MWCNTs) applying the Layer by Layer (LbL) procedure previously developed. 26 Briey, oxidized MWCNTs 27 were treated with a positively charged poly(diallyldimethylammonium) chloride (PDDA) to facilitate the loading of tyrosinase, that is negatively charged at the operative pH 7. Bovine Serum Albumin (BSA) was used to reduce undesired conformational changes.…”
Section: Synthesis Of Dopa-derived Peptidomimetics In Heterogeneous Cmentioning
confidence: 99%
“…29 The structural characterization and the activity parameters of catalyst MWCNT/tyrosinase/BSA (Tyr/ MWCNTs), as well as its application in the synthesis of bioactive catechol derivatives are in ref. 26. The oxidation of BTO 1 (20 mg, 0.068 mmol) with Tyro/MWCNT (600 UA) in PBS/EtOH (7 : 3 v/v, 12 mL) at 25 C for 24 h in the presence of NH 2 -Gly-OMe or N-Boc-Gly-COOH (0.68 mmol) afforded compounds 2 and 3 in 85% and 79% yield, respectively (Table 1, entries 5 and 6).…”
Section: Synthesis Of Dopa-derived Peptidomimetics In Heterogeneous Cmentioning
confidence: 99%
See 1 more Smart Citation
“…Le Roes-Hill et al 2015); biosynthesis of antioxidants (e.g. hydroxytyrosol) (Botta et al 2015), production of prodrugs (e.g. L-DOPA) (Kampmann et al 2016) or compounds suppressing melanoma (Gąsowska-Bajger et al 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Our previous studies have revealed that dipeptides and phenolics—which exhibited various pharmacological activities—are the main active ingredients of this drug [ 5 ]. As part of our continuous work on the systematic study of this insect, the chemical constituents of B. rynchopetera was investigated to afford five new phenolic compounds rynchopeterines A–E ( 1 – 5 ) ( Figure 1 ), along with thirteen known phenolics, procatechuic acid ( 6 ) [ 6 ], 3,4-dihydroxyphenylacetic acid ( 7 ) [ 7 ], 3,4-dihydroxybenzaldehyde ( 8 ) [ 8 ], 3,4-dihydroxyphenylacetaldehyde ( 9 ) [ 9 ], methyl 3,4-dihydroxybenzoate ( 10 ) [ 10 ], 3,4-dihydroxyphenylacetic acid methyl ester ( 11 ) [ 11 ], 3,4-dihydroxyphenylacetic acid ethyl ester ( 12 ) [ 7 ], 2-(3,4-dihydroxyphenyl)ethanol ( 13 ) [ 12 ], 3,4-dihydroxyphenethylacetate ( 14 ) [ 13 ], blapsins A ( 15 ) and B ( 16 ) [ 14 ], 1-(3,4-dimethoxyphenyl)-4-hydroxypentan-1-one ( 17 ) [ 15 ], and 3,3′,4,4′-tetrahydroxybiphenyl ( 18 ) [ 16 ] (see Supplementary ). Herein, the isolation, structural elucidation, and bioactivity of the new compounds are described.…”
Section: Introductionmentioning
confidence: 99%